Meditope Biosciences is revolutionizing the use of monoclonal antibodies. Our proprietary SnAP technology leverages a naturally occurring space in an antibody and carves it into a binding site.
Drawn by a passion for the SnAP technology and all the innovative potential that it represents, the Meditope Biosciences' team represents an impressive and remarkable blend of breadth and depth of experience.
